H
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Hong Wang's research focuses on cardiovascular function, bone metabolism, and infectious diseases, particularly in the context of COVID-19. Wang has investigated myocardial dysfunction using strain imaging and explored biomarkers associated with ferroptosis for treating postmenopausal osteoporosis. Their work also includes studying the role of specific genes, such as RBM20 and ALPK3, in hypertrophic cardiomyopathy. Additionally, Wang has examined the effects of pharmacological interventions like Shuanghuanglian oral liquids on COVID-19 patients and explored the potential cardiovascular health applications of tirzepatide. The researcher's scholarship metrics include an h-index of 19, with 90 total publications and 1,196 total citations. Wang collaborates with researchers such as Xiaolun Sun and Tahrir Alenezi at the University of Arkansas.
Metrics
- h-index: 19
- Publications: 89
- Citations: 1,218
Selected Publications
-
The Mechanistic Target of Rapamycin Mediates Clostridium perfringens-Induced Chicken Necrotic Enteritis Attenuated by Secondary Bile Acid Deoxycholic Acid (2025)
-
Recombinant Bile Salt Hydrolase Enhances the Inhibition Efficiency of Taurodeoxycholic Acid against Clostridium perfringens Virulence (2024)
-
Potent Bile Acid Microbial Metabolites Modulate Clostridium perfringens Virulence (2023)
Collaboration Network
Top Collaborators
Dao Wen Wang
Huazhong University of Science and Technology (CN)
15 shared publications
- Widespread myocardial dysfunction in COVID-19 patients detected by myocardial strain imaging using 2-D speckle-tracking echocardiography
- RBM20 Is a Candidate Gene for Hypertrophic Cardiomyopathy
- The Involvement of ALPK3 in Hypertrophic Cardiomyopathy in East Asia
- Performance evaluation of computational methods for splice-disrupting variants and improving the performance using the machine learning-based framework
- The pattern of late gadolinium enhancement by cardiac MRI in fulminant myocarditis and its prognostic implication: a two-year follow-up study
Showing 5 of 15 shared publications
Zongzhe Li
Huazhong University of Science and Technology (CN)
9 shared publications
- Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled, multicenter clinical trial
- RBM20 Is a Candidate Gene for Hypertrophic Cardiomyopathy
- The Involvement of ALPK3 in Hypertrophic Cardiomyopathy in East Asia
- Aortic Coarctation Associated With Hypertrophic Cardiomyopathy in a Woman With Hypertension and Syncope: A Case Report With 8-Year Follow-Up
- Genetic Profile and Clinical Characteristics of Brugada Syndrome in the Chinese Population
Showing 5 of 9 shared publications
Reading Ashton
8 shared publications
- Supplementary Data from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Supplementary Methods from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Supplementary Figures from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Data from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Supplementary Data from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
Showing 5 of 8 shared publications
Jonathan A. Hensel
8 shared publications
- Supplementary Data from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Supplementary Methods from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Supplementary Figures from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Data from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Supplementary Data from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
Showing 5 of 8 shared publications
Joo Hyoung Lee
8 shared publications
- Supplementary Data from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Supplementary Methods from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Supplementary Figures from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Data from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Supplementary Data from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
Showing 5 of 8 shared publications
Vinayak Khattar
8 shared publications
- Supplementary Data from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Supplementary Methods from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Supplementary Figures from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Data from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Supplementary Data from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
Showing 5 of 8 shared publications
Jessy S. Deshane
8 shared publications
- Supplementary Data from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Supplementary Methods from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Supplementary Figures from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Data from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Supplementary Data from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
Showing 5 of 8 shared publications
Selvarangan Ponnazhagan
8 shared publications
- Supplementary Data from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Supplementary Methods from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Supplementary Figures from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Data from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Supplementary Data from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
Showing 5 of 8 shared publications
Rui Li
Tongji Hospital (CN)
7 shared publications
- Widespread myocardial dysfunction in COVID-19 patients detected by myocardial strain imaging using 2-D speckle-tracking echocardiography
- RBM20 Is a Candidate Gene for Hypertrophic Cardiomyopathy
- The Involvement of ALPK3 in Hypertrophic Cardiomyopathy in East Asia
- Genetic Profile and Clinical Characteristics of Brugada Syndrome in the Chinese Population
- Reassessment of genes associated with dilated and hypertrophic cardiomyopathy in a Chinese Han population
Showing 5 of 7 shared publications
Yang Sun
Tongji Hospital (CN)
7 shared publications
- RBM20 Is a Candidate Gene for Hypertrophic Cardiomyopathy
- The Involvement of ALPK3 in Hypertrophic Cardiomyopathy in East Asia
- Performance evaluation of computational methods for splice-disrupting variants and improving the performance using the machine learning-based framework
- Genetic Profile and Clinical Characteristics of Brugada Syndrome in the Chinese Population
- Reassessment of genes associated with dilated and hypertrophic cardiomyopathy in a Chinese Han population
Showing 5 of 7 shared publications
Xiuli Song
Tongji Hospital (CN)
7 shared publications
- RBM20 Is a Candidate Gene for Hypertrophic Cardiomyopathy
- Autosomal dominant osteopetrosis type II resulting from a <i>de novo </i>mutation in the <i>CLCN7</i> gene: A case report
- Genetic Profile and Clinical Characteristics of Brugada Syndrome in the Chinese Population
- Genetic Profile and Clinical Characteristics of Brugada Syndrome in the Chinese Population
- De novo LAMP2 insertion mutation causes cardiac-only Danon disease: A case report
Showing 5 of 7 shared publications
Yanghui Chen
Huazhong University of Science and Technology (CN)
6 shared publications
- RBM20 Is a Candidate Gene for Hypertrophic Cardiomyopathy
- The Involvement of ALPK3 in Hypertrophic Cardiomyopathy in East Asia
- Genetic Profile and Clinical Characteristics of Brugada Syndrome in the Chinese Population
- Reassessment of genes associated with dilated and hypertrophic cardiomyopathy in a Chinese Han population
- Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
Showing 5 of 6 shared publications
Yong Wang
6 shared publications
- Supplementary Data from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Supplementary Methods from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Supplementary Figures from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Supplementary Data from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Supplementary Figures from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
Showing 5 of 6 shared publications
Fei Ma
Tongji Hospital (CN)
5 shared publications
- Widespread myocardial dysfunction in COVID-19 patients detected by myocardial strain imaging using 2-D speckle-tracking echocardiography
- Long-term cardiac remodeling associated with heart failure following left-ventricular valve replacement surgery
- Genetic Profile and Clinical Characteristics of Brugada Syndrome in the Chinese Population
- Genetic Profile and Clinical Characteristics of Brugada Syndrome in the Chinese Population
- Reassessment of genes associated with dilated and hypertrophic cardiomyopathy in a Chinese Han population
Jiaqi Dai
Huazhong University of Science and Technology (CN)
5 shared publications
- RBM20 Is a Candidate Gene for Hypertrophic Cardiomyopathy
- The Involvement of ALPK3 in Hypertrophic Cardiomyopathy in East Asia
- Performance evaluation of computational methods for splice-disrupting variants and improving the performance using the machine learning-based framework
- Reassessment of genes associated with dilated and hypertrophic cardiomyopathy in a Chinese Han population
- Machine learning modeling identifies hypertrophic cardiomyopathy subtypes with genetic signature
Similar Researchers
Based on overlapping research topics
Bhawana Adhikari
University of Arkansas for Medical Sciences
Cardiovascular Function and Risk Factors
Bone health and treatments
Metabolism and Genetic Disorders
Na Li
Harding University Main Campus
Cardiovascular Function and Risk Factors
SARS-CoV-2 and COVID-19 Research
Metabolism and Genetic Disorders
Daniel Mak
University of Arkansas for Medical Sciences
Cardiovascular Function and Risk Factors
SARS-CoV-2 and COVID-19 Research
COVID-19 Clinical Research Studies
Heather Elias
Arkansas State University
Cardiovascular Function and Risk Factors
SARS-CoV-2 and COVID-19 Research
COVID-19 Clinical Research Studies
K Sawalha
University of Arkansas for Medical Sciences
Cardiovascular Function and Risk Factors
SARS-CoV-2 and COVID-19 Research
Metabolism and Genetic Disorders
Christine Rutlen
University of Arkansas for Medical Sciences
Cardiovascular Function and Risk Factors
SARS-CoV-2 and COVID-19 Research
COVID-19 Clinical Research Studies